$RKLB

Clevenger Marvin Bradford sold $2.2M of RKLB

Clevenger Marvin Bradford (President, Rocket Lab USA, Inc) sold 15,549 shares of Rocket Lab Corp (RKLB) at an average of $142.57 ($139.41–$144.13, $2.22M total) across 6 trades on 2026-05-26.

Original reporting
SEC EDGAR · Clevenger Marvin Bradford
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale of 15,549 shares totaling about $2.22M, executed 2026-05-26 and filed 2026-05-28.

02

Market read

Traders may briefly reassess sentiment around RKLB due to a sizable insider sale, but there is no fundamental update in the text.

03

What to watch

No context is provided on diversification needs, tax planning, or whether other insiders sold/bought around the same time; without that, the trading read-through is weak.

Relevance 6/10Novelty 5/10Timing: filed 2026-05-28, discloses sale executed 2026-05-26

Background

This is an SEC Form 4 insider transaction disclosure for Rocket Lab Corp, reported by an officer (President, Rocket Lab USA, Inc).

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab insider Form 4 shows President of Rocket Lab USA sold $2.22M of RKLB shares in open-market trades at $139.41 to $144.13.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-through only if additional insider selling or new fundamentals emerge.

Evidence & confidence

The article discloses a large dollar amount of insider selling ($2.22M) but provides no accompanying company news (no guidance, contract, or regulatory action).

Market effects

Minimal; insider sales in a single space/defense-adjacent name typically do not reset sector expectations without additional news.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine liquidity events, especially when not tied to a 10b5-1 plan, so the signal may be overstated versus fundamentals.

Key entities

  • Rocket Lab Corp

    Subject of the Form 4 insider sale disclosure.

  • Clevenger Marvin Bradford

    Officer reporting the sale; President, Rocket Lab USA, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBHigh

Rocket Lab (RKLB) Stock Drops After Neutron Rocket Launch Delay

Rocket Lab (RKLB) shares fell 7.9% during trading and 7.3% after-hours after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company's P/S ratio is 45.17, above historical and industry averages, reflecting high growth expectations. Insider selling totaled $683.3 million over the past year. Rocket Lab has a GF Score of 77/100, indicating strong financial health but weak profitability.

$RKLBMed

Rocket Lab pushes Neutron rocket's debut flight to 2027, shares fall

Rocket Lab announced a delay in the debut flight of its Neutron rocket to 2027, pushing back from the previously targeted fourth quarter of 2026. The news caused the company's shares to drop about 6% in extended trading. Neutron is a reusable medium-lift rocket aimed at competing for larger commercial and national-security missions. Recently, Rocket Lab secured a multi-year launch agreement for 20 missions with Tokyo-based Synspective.

$RKLBHigh

Why is Rocket Lab stock tumbling today?

Rocket Lab (RKLB) stock dropped 7.2% in after-hours trading after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company also faces insider-selling pressure and a challenging macro environment with rising Fed rate hike bets. The stock is down over 60% from its 52-week high.

$RKLBHigh

Rocket Lab Stock Stumbles Despite Big Space Ambitions

Rocket Lab USA (RKLB) shares fell 8% during and after trading due to CEO Peter Beck's planned stock sale, SpaceX funding concerns, and a delay in the Neutron rocket launch to 2027. Despite record Q2 revenue of $234M and a strong backlog, investors worry about integration risks and profitability. Analysts maintain a Strong Buy rating with a $104.44 price target.